POLYMORPHS OF 2-(4-(2-(1-ISOPROPYL-3-METHYL-1H-1,2,4-TRIAZOL-5-YL)-5,6-DIHYDROBENZO[F]IMIDAZO[1,2-D][1,4]OXAZEPIN-9-YL)-1H-PYRAZOL-1-YL)-2-METHYLPROPANAMIDE, METHODS OF PRODUCTION AND PHARMACEUTICAL USES THEREOF Russian patent published in 2018 - IPC C07D498/04 A61K31/553 A61P35/00 

Abstract RU 2658009 C2

FIELD: chemistry.

SUBSTANCE: invention relates to a process for the preparation of the crystalline polymorph of 2-(4-(2-(1-isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl)-1H-pyrazol-1-yl)-2-methylpropanamide (GDC-0032, taselisib), comprising heating the suspension in isoamyl alcohol and cooling the mixture, whereby a crystalline polymorph is formed, characterized by an X-ray powder diffraction pattern, having characteristic peaks expressed in 2-theta degrees at approximately 9.40, 10.84, 16.72, 18.7 and 26.60.

EFFECT: method for preparing the crystalline polymorph of 2-(4-(2-(1-isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl)-1H-pyrazol-1-yl)-2-methylpropanamide, which has hygroscopicity, physical stability, chemical stability in the solid state.

1 cl, 21 dwg, 15 tbl, 13 ex

Similar patents RU2658009C2

Title Year Author Number
CRYSTALLINE FORMS OF 6-(1H-IMIDAZOL-1-YL)-2-PHENYLQUINAZOLINE AND ITS SALTS 2010
  • Dzhordani Antonio
  • Mandelli Stefano
  • Porta Francheska
  • Girri Matteo
  • Rovati Luchio Klaudio
RU2557547C2
CRYSTALLINE SOLVATES OF HYDROCHLORIDE 6-(PIPERIDIN-4-YLOXY)-2H-ISOQUINOLIN-1-ONE 2012
  • Nagel Norbert
  • Baumgartner Bruno
  • Berkhtold Kharald
  • Plettenburg Oliver
  • Kaderajt Diter
  • Monikke Mandi
  • Gessler Zimon
  • Tillner Joakhim
RU2619129C2
SOLID FORMS OF 2-(5-(4-(2-MORPHOLINOETHOXY)PHENYL)PYRIDINE-2-IL)-N-BENZYLACETAMIDE 2018
  • Smolinski, Michael P.
RU2802964C2
SALTS AND POLYMORPHS OF SUBSTITUTED IMIDAZOPYRIDINYL-AMINOPYRIDINE 2015
  • Bates, Craig
  • Mao, Jianmin
  • Reed, David
RU2732125C2
SOLID FORMS OF EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR 2013
  • Laj Mej
RU2673077C2
3-[1,2,3,6-TETRAHYDROPYRIDIN-2-YL]PYRIDINE GLUTARATE OR PHARMACEUTICALLY ACCEPTABLE SOLVATE THEREOF 2019
  • Mazurov, Anatoly
RU2823979C2
SOLID FORMS OF 3-(5-AMINO-2-METHYL-4-OXO-4H-QUINAZOLIN-3-YL)PIPERIDINE-2,6-DIONE DERIVATIVES AND THEIR PHARMACEUTICAL COMPOSITIONS AND USE 2012
  • Myuller Dzhordzh V.
  • Man Khon-Vakh
  • Koen Bendzhamin M.
  • Li In
  • Syuj Dzhin
  • Leong Uillyam V.
RU2611007C2
SALTS OF EPIDERMAL GROWTH FACTOR RECEPTOR KINASE 2013
  • Laj Mej
  • Vitovski Stiven Richard
  • Tester Richland Vejn
  • Li Kvangkho
RU2711077C2
9E-15-(2-PYRROLIDIN-1-YL-ETHOXY)-7,12,25-TRIOXA-19,21,24-TRIAZATETRACYCLO[18.3.1.1(2,5). 1(14,18)]HEXACOSA-1(24),2,4,9,14,16,18(26),20,22-NONAENE CITRATE SALT 2010
  • Dajmok Brajan
  • Li Chehn' Khsija Andzhelin
  • Vil'Jam Ehntoni Deodonija
RU2543721C2
CRYSTALLINE FORMS OF 3-[5-(2-FLUOROPHENYL)-[1,2,4]OXADIAZOL-3-YL]BENZOIC ACID, AND USE THEREOF AND METHODS FOR PREPARING 2007
  • Al'Msted Nil G.
  • Khvang Piter Seongvoo
  • Moon Joung-Choon
RU2474577C2

RU 2 658 009 C2

Authors

Stalts Dzheffri

Dates

2018-06-19Published

2014-12-15Filed